New cell therapy shows promise for rare sarcoma
Disease control
Recruiting now
This study tests a new treatment called TBI-1301 (mip-cel) for people with a rare type of cancer called synovial sarcoma. The treatment uses the patient's own immune cells, modified to attack cancer cells. The goal is to see if it can shrink tumors safely. The study is for adults…
Phase: PHASE3 • Sponsor: Takara Bio Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC